Clesrovimab, formerly known as MK-1654, is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody.

The modified vaccinia Ankara-Bavarian Nordic mpox vaccine (MVA-BN; Jynneos) generated robust immune responses in adolescents ...

A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent ...

Older adults who received the bivalent BNT162b2 vaccine were less likely to develop long COVID symptoms follow acute ...

When it was prescribed within a week of SARS CoV-2 infection, metformin was associated with a 53% reduction in long COVID or ...

Treating hospitalized patients with bloodstream infections with antibiotics for seven days is noninferior to treating for 14 ...

Investigators compared test results from the user-collected vaginal swab samples against those from healthcare ...

During the monitoring period, after the seasonal influenza period had ended, 59 wastewater treatment plants showed increases ...

Pharmaceuticals announced the presentation of a scientific poster at the Infectious Diseases Society of America IDWeek 2024 ...

A new study presented at IDWeek 2024 reveals that race and socioeconomic vulnerabilities significantly impact vaccine uptake ...

Sep. 25, 2024 — Almost everyone knows about HIV. Fewer people know about its relative, HTLV-1. However, HTLV-1 can cause serious illnesses, including cancer. To develop ways to combat this virus ...

New IDWeek 2024 study reveals disparities in PrEP uptake across key U.S. populations. While overall PrEP usage has increased, ...